Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

The Global Medical Cannabis Market is Projected to Reach $44.4 Billion by 2024, Growing at a CAGR of 22.9% - ResearchAndMarkets.com

May 2, 2019

DUBLIN--(BUSINESS WIRE)--May 2, 2019--The “Medical Cannabis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s offering.

The global medical cannabis market size was estimated to reach a value of US$ 13.4 Billion in 2018. The market is further expected to reach value of US$ 44.4 Billion by 2024, exhibiting a CAGR of 22.9% during 2019-2024.

Nowadays, cannabis finds application in the treatment of a wide range of diseases and symptoms including cancer, chronic pain, depression, arthritis, diabetes, glaucoma, migraines, epilepsy, MS, AIDS, ALS, Alzheimer’s, PTSD, Parkinson’s, Tourette’s, etc.

Owing to its therapeutic benefits, cannabis has been approved for medical use in numerous countries, with varying degrees of legal restriction. Some of these countries include Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Germany, Italy, Mexico, Spain, United Kingdom, United States, Uruguay, etc.

Market Drivers

Cannabis is safer and has less severe side effects in comparison to other treatment options. It also finds usage along with other treatments either to enhance their effect or to combat negative side effects. For instance, cannabis is very effective in reducing nausea and increasing appetite among the chemotherapy patients, making the agonizing treatment more tolerable.

Similarly, it is also used in combination with traditional opioid painkillers, which enables patients to significantly reduce the dosage and frequency of opioids, and also imparts greater pain relief.

A steadily rising ageing population has also played an significant role in driving the demand for medical cannabis as geriatric patients are more likely to develop chronic illnesses and require more physician visits.

Clinical trials, R&D activities and commercialization of cannabis-based indications are further expected to catalyze the growth of the market.

Although expenditure on health products are less susceptible to fluctuations in consumer’s expenditure, the uptake of medical marijuana is liable to changes in disposable income due to its unconventional nature. As a result, we expect increasing disposable incomes to create a positive impact on the demand of medical cannabis.

Breakup by Species

On the basis of species, the market has been segmented as Indica, Sativa and hybrid. Currently, Indica dominates the market, holding the largest share. It is often used in the treatment of insomnia, relaxing the muscles, relieving body pains, headaches and migraines.

Breakup by Derivatives

Based on derivatives, the market has been divided into Cannabidiol (CBD), Tetrahydrocannabinol (THC) and others. CBD is majorly used for medical purposes due to its non-psychotic effect and low levels of toxicity, whereas, THC is utilised to reduce the side-effects of AIDS and cancer treatment.

Breakup by Application

The market has also been divided on the basis of application, wherein, cancer represents the leading category. Other major applications of cannabis include arthritis, migraine, epilepsy, etc.

Breakup by End-Use

On the basis of end-use, the market has been segregated into the pharmaceutical industry, research and development centers, and others. Currently, the pharmaceutical industry represents the biggest end-user.

Breakup by Route of Administration

Based on route of administration, the market has been categorized into oral solutions and capsules, smoking, vaporizers, topicals and others. Oral solutions and capsules represent the biggest segment, accounting for the largest market share.

Regional Insights

On a geographical front, North America enjoys the leading position in the market. Recent legalization of cannabis in North America for both recreational and medical purposes has been a major driver of the market growth. Other key regions include Europe, Asia Pacific, Latin America, and Middle East and Africa.

Some of the major players include:

  • Canopy Growth Corporation
  • GW Pharmaceuticals
  • Aurora Cannabis Inc.
  • Aphria Inc.
  • MedReleaf Corporation
  • Insys Therapeutics Inc.
  • CanniMed Therapeutics Inc.
  • Cara Therapeutics Inc.
  • United Cannabis Corporation

Key Topics Covered

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.4 Market Estimation

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Medical Cannabis Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Breakup by Species

5.4 Market Breakup by Derivative

5.5 Market Breakup by Application

5.6 Market Breakup by End-Use

5.7 Market Breakup by Route of Administration

5.8 Market Breakup by Region

5.9 Market Forecast

5.10 SWOT Analysis

5.11 Value Chain Analysis

5.12 Porters Five Forces Analysis

5.13 Key Success and Risk Factors

6 Market Breakup by Species

6.1 Indica

6.2 Sativa

6.3 Hybrid

7 Market Breakup by Derivative

7.1 Cannabidiol (CBD)

7.2 Tetrahydrocannabinol (THC)

7.3 Others

8 Market Breakup by Application

8.1 Cancer

8.2 Arthritis

8.3 Migraine

8.4 Epilepsy

8.5 Others

9 Market Breakup by End-Use

9.1 Pharmaceutical Industry

9.2 Research and Development Centres

9.3 Others

10 Market Breakup by Route of Administration

10.1 Oral Solutions and Capsules

10.2 Smoking

10.3 Vaporizers

10.4 Topicals

10.5 Others

11 Market Breakup by Region

11.1 North America

11.2 Europe

11.3 Latin America

11.4 Asia Pacific

11.5 Middle East and Africa

12 Overview of Clinical Research Suggesting the Benefits of Medical Cannabis Across Various Indications

12.1 Alzheimer’s Disease

12.2 Autism

12.3 Cancer

12.4 Chronic Pain

12.5 Epilepsy

12.6 Migraine

12.7 Digestive Disorders

12.8 Multiple Sclerosis

12.9 Schizophrenia

12.10 Others

13 Competitive Landscape

13.1 Market Structure

13.2 Key Players

14 Key Player Profiles

For more information about this report visit https://www.researchandmarkets.com/r/rxqheo

View source version on businesswire.com:https://www.businesswire.com/news/home/20190502005732/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Analgesics



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/02/2019 01:29 PM/DISC: 05/02/2019 01:29 PM